Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 1
2005 1
2006 1
2007 1
2008 1
2011 1
2012 1
2015 1
2016 3
2017 5
2018 1
2019 3
2020 3
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean l ciani[Author] (130 results)?
Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.
Levi Sandri GB, Ettorre GM, Giannelli V, Colasanti M, Sciuto R, Pizzi G, Cianni R, D'Offizi G, Antonini M, Vennarecci G, Lucatelli P. Levi Sandri GB, et al. Among authors: cianni r. Transl Gastroenterol Hepatol. 2017 Nov 27;2:98. doi: 10.21037/tgh.2017.11.11. eCollection 2017. Transl Gastroenterol Hepatol. 2017. PMID: 29264436 Free PMC article. Review.
A comparative study of warheads for design of cysteine protease inhibitors.
Silva DG, Ribeiro JFR, De Vita D, Cianni L, Franco CH, Freitas-Junior LH, Moraes CB, Rocha JR, Burtoloso ACB, Kenny PW, Leitão A, Montanari CA. Silva DG, et al. Among authors: cianni l. Bioorg Med Chem Lett. 2017 Nov 15;27(22):5031-5035. doi: 10.1016/j.bmcl.2017.10.002. Epub 2017 Oct 3. Bioorg Med Chem Lett. 2017. PMID: 29054358
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
Ettorre GM, Levi Sandri GB, Laurenzi A, Colasanti M, Meniconi RL, Lionetti R, Santoro R, Lepiane P, Sciuto R, Pizzi G, Cianni R, Golfieri R, D'Offizi G, Pellicelli AM, Antonini M, Vennarecci G. Ettorre GM, et al. Among authors: cianni r. World J Surg. 2017 Jan;41(1):241-249. doi: 10.1007/s00268-016-3682-z. World J Surg. 2017. PMID: 27495316
N-Sulfonyl dipeptide nitriles as inhibitors of human cathepsin S: In silico design, synthesis and biochemical characterization.
Lemke C, Cianni L, Feldmann C, Gilberg E, Yin J, Dos Reis Rocho F, de Vita D, Bartz U, Bajorath J, Montanari CA, Gütschow M. Lemke C, et al. Among authors: cianni l. Bioorg Med Chem Lett. 2020 Sep 15;30(18):127420. doi: 10.1016/j.bmcl.2020.127420. Epub 2020 Jul 17. Bioorg Med Chem Lett. 2020. PMID: 32763808
Kinetic investigations were performed at four human cysteine proteases, i.e. cathepsins S, B, K and L. Compound 12 with a terminal 3-biphenyl sulfonamide substituent was the most potent (K(i) = 4.02 nM; selectivity ratio cathepsin S/K = 5.8; S/L = 67) and 24 with a …
Kinetic investigations were performed at four human cysteine proteases, i.e. cathepsins S, B, K and L. Compound 12 with a terminal 3- …
Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
Ribeiro JFR, Cianni L, Li C, Warwick TG, de Vita D, Rosini F, Dos Reis Rocho F, Martins FCP, Kenny PW, Lameira J, Leitão A, Emsley J, Montanari CA. Ribeiro JFR, et al. Among authors: cianni l. Bioorg Med Chem. 2020 Nov 15;28(22):115743. doi: 10.1016/j.bmc.2020.115743. Epub 2020 Sep 6. Bioorg Med Chem. 2020. PMID: 33038787
We also tested the same series of inhibitors on related cysteine proteases cathepsin L and Trypanosoma cruzi cruzain. The modulation of these mammalian and protozoan proteases represents a new framework for targeting papain-like cysteine proteases....
We also tested the same series of inhibitors on related cysteine proteases cathepsin L and Trypanosoma cruzi cruzain. The modulation …
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting.
Simioni N, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Lapolla A, Bette C, Rossi MC; ReaL (NN2211-4118) Study Group*. Simioni N, et al. Among authors: di cianni g. Acta Diabetol. 2018 Jun;55(6):557-568. doi: 10.1007/s00592-018-1124-0. Epub 2018 Mar 12. Acta Diabetol. 2018. PMID: 29527621 Free PMC article.
Intramedullary nailing vs modular megaprosthesis in extracapsular metastases of proximal femur: clinical outcomes and complication in a retrospective study.
Vitiello R, Perisano C, Greco T, Cianni L, Polichetti C, Comodo RM, De Martino I, La Vergata V, Maccauro G. Vitiello R, et al. Among authors: cianni l. BMC Musculoskelet Disord. 2022 Sep 13;22(Suppl 2):1069. doi: 10.1186/s12891-022-05728-5. BMC Musculoskelet Disord. 2022. PMID: 36100879 Free PMC article.
The patients of intramedullary group showed malnutrition (Albumin: 30.5 6.5 vs 37.6 6 g/L; p = 0.03) and pro-inflammatory state (NLR: 7.1 6.7 vs 3.8 2.4; p = 0.05) (PLR: 312 203 vs 194 99; p = 0.04) greater than megaprostheses group. ...
The patients of intramedullary group showed malnutrition (Albumin: 30.5 6.5 vs 37.6 6 g/L; p = 0.03) and pro-inflammatory state (NLR: …
Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients.
Marchetti P, Gregorio F, Benzi L, Giannarelli R, Cecchetti P, Villani G, Di Cianni G, Di Carlo A, Brunetti P, Navalesi R. Marchetti P, et al. Among authors: di cianni g. Diabete Metab. 1990 Dec;16(6):473-8. Diabete Metab. 1990. PMID: 2086278
At the two different daily doses fasting plasma metformin concentrations were similar (3.23 +/- 0.35 mumol/l and 3.86 +/- 0.72 mumol/l, mean values +/- SEM, at low and high dose respectively). Drug peak values and averaged concentrations (4.66 +/- 0.39 mumol/l …
At the two different daily doses fasting plasma metformin concentrations were similar (3.23 +/- 0.35 mumol/l and 3.86 +/- 0.72 mumol/ …
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study.
Vitale M, Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Nicolucci A, Squatrito S, Auciello S, Babini AC, Bani L, Buzzetti R, Cannarsa E, Cignarelli M, Cigolini M, Clemente G, Cocozza S, Corsi L, D'Angelo F, Dall'Aglio E, Di Cianni G, Fontana L, Gregori G, Grioni S, Giordano C, Iannarelli R, Iovine C, Lapolla A, Lauro D, Laviola L, Mazzucchelli C, Signorini S, Tonutti L, Trevisan R, Zamboni C, Riccardi G, Rivellese AA; TOSCA.IT Study Group. Vitale M, et al. Among authors: di cianni g. Clin Nutr. 2017 Dec;36(6):1686-1692. doi: 10.1016/j.clnu.2016.11.002. Epub 2016 Nov 14. Clin Nutr. 2017. PMID: 27890487 Clinical Trial.
23 results